Petra Pharma
company
About
Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $48M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Close
Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies for serious medical conditions such as cancer and metabolic diseases. The company also focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. It will develop novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health.Petra Pharma was founded in 2016 and is headquartered in New York, USA.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$48M
Petra Pharma has raised a total of
$48M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2016 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2016 | Series A | $48M | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Petra Pharma is funded by 4 investors.
ARCH Venture Partners
and WuXi PharmaTech
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
